Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Jan;87(1):75-9.
doi: 10.1073/pnas.87.1.75.

Fibroblast-mediated acceleration of human epithelial tumor growth in vivo

Affiliations

Fibroblast-mediated acceleration of human epithelial tumor growth in vivo

J L Camps et al. Proc Natl Acad Sci U S A. 1990 Jan.

Abstract

Transformed fibroblasts coinoculated with epithelial cells accelerated the growth and shortened the latency period of human epithelial tumors in athymic mice. Addition of NbF-1 fibroblasts caused epithelial tumors to grow from five marginally tumorigenic or "nontumorigenic" (nontumor-forming) human tumor cell lines or strains: PC-3 (prostate), WH (bladder), MDA-436 (breast), and cells derived from the ascites fluids of patients with metastatic renal pelvic or prostate cancers. Evidence for the human and epithelial nature of these experimental tumors was provided by histologic, immunohistochemical, Southern and dot-blot hybridization, and cytogenetic analyses. Transformed fibroblasts induced predominantly carcinosarcomas, whereas nontumorigenic fibroblasts (NIH 3T3) and lethally irradiated transformed fibroblasts induced exclusively carcinomas. The fibroblast-epithelial interaction appears to occur bidirectionally and does not result from cell fusion. Because coculture experiments in vitro did not demonstrate an increased cell proliferation, it appears that undefined host factors can influence tumor growth. This tumor model may be useful in drug-screening programs and in mechanistic studies of factors regulating human tumor growth and progression.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cancer Res. 1989 May 15;49(10):2750-4 - PubMed
    1. Endocrinology. 1986 Jun;118(6):2437-44 - PubMed
    1. Natl Cancer Inst Monogr. 1967 Sep;26:279-99 - PubMed
    1. Science. 1970 Mar 27;167(3926):1736-8 - PubMed
    1. J Natl Cancer Inst. 1972 Nov;49(5):1425-31 - PubMed

Publication types

MeSH terms